Streptozotocin diabetic mice display depressive-like behavior and alterations in the structure, neurotransmission and plasticity of medial prefrontal cortex interneurons

Brain Research Bulletin

Volumn 116, Issue , 2015, Pages 45-56

  Castillo Gómez, Esther ^a,e,f   Coviello, Simona ^a   Perez Rando, Marta ^a   Curto, Yasmina ^a   Carceller, Héctor ^a   Salvador, Alicia ^a,d   Nacher, Juan ^a,b,c,d  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c Instituto Universitario IVI INCLIVA   (Spain)

^d VLC Campus Res Microcluster Technol of Inf Control Appl to Patophysiol and Treat of Diabetes   (Spain)

^e MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^f Clinical Neuroscience Max Planck Institute of Experimental Medicine ^*  (Spain)

Author keywords

Depression; Diabetes; Interneuron; Stress; Structural plasticity

Indexed keywords

4 AMINOBUTYRIC ACID; GLUCOSE; GLUTAMATE DECARBOXYLASE 67; NERVE CELL ADHESION MOLECULE; SYNAPTOPHYSIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1; GREEN FLUORESCENT PROTEIN; NERVE CELL ADHESION MOLECULE L1; POLYSIALYL NEURAL CELL ADHESION MOLECULE; SIALIC ACID DERIVATIVE; SYP PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN REGION; CONTROLLED STUDY; DENDRITIC CELL; DEPRESSION; GLUCOSE BLOOD LEVEL; IMMOBILITY; IMMUNOHISTOCHEMISTRY; INTERNEURON; MALE; MEDIAL PREFRONTAL CORTEX; MOUSE; NERVE CELL PLASTICITY; NEUROPIL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TAIL SUSPENSION TEST; TRANSGENIC MOUSE; WEIGHT REDUCTION; YOUNG ADULT; ANIMAL; DENDRITE; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; PSYCHOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; DENDRITES; DEPRESSIVE DISORDER; DIABETES MELLITUS, EXPERIMENTAL; GLUTAMATE DECARBOXYLASE; GREEN FLUORESCENT PROTEINS; INTERNEURONS; MALE; MICE, TRANSGENIC; NEURAL CELL ADHESION MOLECULE L1; NEURONAL PLASTICITY; PREFRONTAL CORTEX; SIALIC ACIDS; SYNAPTIC TRANSMISSION; SYNAPTOPHYSIN;

EID: 84932647469     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2015.06.002     Document Type: Article

References (75)

1. Alvarez A., Faccioli J., Guinzbourg M., Castex M.M., Bayón C., Masson W., Bluro I., Kozak A., Sorroche P., Capurro L., Grosembacher L., Proietti A., Finkelsztein C., Costa L., Fainstein Day P., Cagide A., Litwak L.E., Golden S.H. Endocrine and inflammatory profiles in type 2 diabetic patients with and without major depressive disorder. BMC Res. Notes 2013, 6:61.
2. Anderson R.J., Freedland K.E., Clouse R.E., Lustman P.J. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001, 24:1069-1078.
3. Bestetti G., Locatelli V., Tirone F., Rossi G.L., Müller E.E. One month of streptozotocin-diabetes induces different neuroendocrine and morphological alterations in the hypothalamo-pituitary axis of male and female rats. Endocrinology 1985, 117:208-216.
4. Bestetti G., Rossi G.L. Hypothalamic lesions in rats with long-term streptozotocin-induced diabetes mellitus. A semiquantitative light- and electron-microscopic study. Acta Neuropathol. 1980, 52:119-127.
5. Biessels G.J., Kamal A., Ramakers G.M., Urban I.J., Spruijt B.M., Erkelens D.W., Gispen W.H. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 1996, 45:1259-1266.
6. Brambilla P., Perez J., Barale F., Schettini G., Soares J.C. GABAergic dysfunction in mood disorders. Mol. Psychiatry 2003, 715:721-737.
7. Brody A.L., Barsom M.W., Bota R.G., Saxena S. Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Semin. Clin. Neuropsychiatry 2001, 6:102-112.
8. Castillo-Gómez E., Gómez-Climent M.A., Varea E., Guirado R., Blasco-Ibáñez J.M., Crespo C., Martínez-Guijarro F.J., Nácher J. Dopamine acting through D2 receptors modulates the expression of PSA-NCAM, a molecule related to neuronal structural plasticity, in the medial prefrontal cortex of adult rats. Exp. Neurol. 2008, 214:97-111.
9. Castillo-Gómez E., Varea E., Blasco-Ibáñez J.M., Crespo C., Nacher J. Polysialic acid is required for dopamine D2 receptor-mediated plasticity involving inhibitory circuits of the rat medial prefrontal cortex. PLoS One 2011, 6.
10. Cordero M.I., Rodríguez J.J., Davies H.A., Peddie C.J., Sandi C., Stewart M.G. Chronic restraint stress down-regulates amygdaloid expression of polysialylated neural cell adhesion molecule. Neuroscience 2005, 133:903-910.
11. De Nicola A.F., Fridman O., Del Castillo E.J., Foglia V.G. Abnormal regulation of adrenal function in rats with streptozotocin diabetes. Horm. Metab. Res. 1977, 9:469-473.
12. Djordjevic A., Djordjevic J., Elaković I., Adzic M., Matić G., Radojcic M.B. Effects of fluoxetine on plasticity and apoptosis evoked by chronic stress in rat prefrontal cortex. Eur. J. Pharmacol. 2012, 693:37-44.
13. Djordjevic J., Djordjevic A., Adzic M., Radojcic M.B. Effects of chronic social isolation on Wistar rat behavior and brain plasticity markers. Neuropsychobiology 2012, 66:112-119.
14. Doyle T., Halaris A., Rao M. Shared neurobiological pathways between type 2 diabetes and depressive symptoms: a review of morphological and neurocognitive findings. Curr. Diab Rep. 2014, 14:560.
15. Falip M., Carreño M., Miró J., Saiz A., Villanueva V., Quílez A., Molins A., Barceló I., Sierra A., Graus F. Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies. Eur. J. Neurol. 2012, 19:827-833.
16. Figlewicz D.P., Brot M.D., McCall A.L., Szot P. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res. 1996, 736:54-60.
17. Gardoni F., Kamal A., Bellone C., Biessels G.J., Ramakers G.M.J., Cattabeni F., Gispent W.H., Di Luca M. Effects of streptozotocin-diabetes on the hippocampal NMDA receptor complex in rats. J. Neurochem. 2002, 80:438-447.
18. Gilabert-Juan J., Castillo-Gomez E., Guirado R., Moltó M.D., Nacher J. Chronic stress alters inhibitory networks in the medial prefrontal cortex of adult mice, Brain Struct. Funct. 2013, 218:1591-1605.
19. Gilabert-Juan J., Castillo-Gomez E., Pérez-Rando M., Moltó M.D., Nacher J. Chronic stress induces changes in the structure of interneurons and in the expression of molecules related to neuronal structural plasticity and inhibitory neurotransmission in the amygdala of adult mice. Exp. Neurol. 2011, 232:33-40.
20. Gomez R., Vargas C.R., Wajner M., Barros H.M.T. Lower in vivo brain extracellular GABA concentration in diabetic rats during forced swimming. Brain Res. 2003, 968:281-284.
21. Gómez-Climent M., Guirado R., Castillo-Gómez E., Varea E., Gutierrez-Mecinas M., Gilabert-Juan J., García-Mompó C., Vidueira S., Sanchez-Mataredona D., Hernández S., Blasco-Ibáñez J.M., Crespo C., Rutishauser U., Schachner M., Nacher J. The polysialylated form of the neural cell adhesion molecule (PSA-NCAM) is expressed in a subpopulation of mature cortical interneurons characterized by reduced structural features and connectivity. Cereb. Cortex 2011, 21:1028-1041.
22. Greengard P., Valtorta F., Czernik A.J., Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 1993, 259:780-785.
23. Guirado R., Perez-Rando M., Sanchez-Matarredona D., Castillo-Gómez E., Liberia T., Rovira-Esteban L., Varea E., Crespo C., Blasco-Ibáñez J.M., Nacher J. The Dendritic Spines of Interneurons Are Dynamic Structures Influenced by PSA-NCAM Expression. Cereb. Cortex 2014, 24:3014-3024.
24. Guirado R., Sanchez-Matarredona D., Varea E., Crespo C., Blasco-Ibáñez J.M., Nacher J. Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesis. BMC Neurosci. 2012, 13:5.
25. Gupta D., Kurhe Y., Radhakrishnan M. Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system. Physiol. Behav. 2014, 129:73-78.
26. Guyot L.L., Diaz F.G., O'Regan M.H., Song D., Phillis J.W. The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex. Neurosurgery 2001, 48:385-390.
27. Hasler G., van der Veen J.W., Tumonis T., Meyers N., Shen J., Drevets W.C. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 2007, 64:193-200.
28. Ho N., Balu D.T., Hilario M.R.F., Blendy J.A., Lucki I. Depressive phenotypes evoked by experimental diabetes are reversed by insulin. Physiol. Behav. 2012, 105:702-708.
29. Honda M., Inoue M., Okada Y., Yamamoto M. Alteration of the GABAergic neuronal system of the retina and superior colliculus in streptozotocin-induced diabetic rat. Kobe J. Med. Sci. 1998, 44:1-8.
30. Jakobsen J., Sidenius P., Gundersen H.J., Osterby R. Quantitative changes of cerebral neocortical structure in insulin-treated long-term streptozocin-induced diabetes in rats. Diabetes 1987, 36:597-601.
31. Joghataie M.-T., Roghani M., Jalali M.-R., Baluchnejadmojarad T., Sharayeli M. Dendritic spine changes in medial prefrontal cortex of male diabetic rats using Golgi-impregnation method. Arch. Iran Med. 2007.
32. Kamal A., Biessels G.-J., Gispen W.H., Ramakers G.M.J. Synaptic transmission changes in the pyramidal cells of the hippocampus in streptozotocin-induced diabetes mellitus in rats. Brain Res. 2006, 1073-1074:276-280.
33. Karolewicz B., Maciag D., O'Dwyer G., Stockmeier C.A., Feyissa A.M., Rajkowska G. Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. Int. J. Neuropsychopharmacol. 2010, 13:411-420.
34. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
35. Krystal J.H., Sanacora G., Blumberg H., Anand A., Charney D.S., Marek G., Epperson C.N., Goddard A., Mason G.F. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol. Psychiatry 2002, 1(7 (Suppl.)):S71-S80.
36. Longair M.H., Baker D.A., Armstrong J.D. Simple Neurite Tracer: open source software for reconstruction, visualization and analysis of neuronal processes. Bioinformatics 2011, 27:2453-2454.
37. Luscher B., Shen Q., Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol. Psychiatry 2011, 16:383-406.
38. Ma Y., Hu H., Berrebi A.S., Mathers P.H., Agmon A. Distinct subtypes of somatostatin-containing neocortical interneurons revealed in transgenic mice. J. Neurosci. 2006, 26:5069-5082.
39. Magariños A.M., McEwen B.S. Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11056-11061.
40. Martínez-Tellez R., Gómez-Villalobos de M.J., Flores G. Alteration in dendritic morphology of cortical neurons in rats with diabetes mellitus induced by streptozotocin. Brain Res. 2005, 1048:108-115.
41. Masliah E., Terry R.D., Alford M., DeTeresa R. Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J. Histochem. Cytochem. 1990, 38:837-844.
42. McEwen B.S. The neurobiology of stress: from serendipity to clinical relevance. Brain Res. 2000, 886:172-189.
43. McEwen B.S. Mood disorders and allostatic load. Biol. Psychiatry 2003, 54:200-207.
44. McEwen B.S., Morrison J.H. The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course. Neuron 2013, 79:16-29.
45. Miyata S., Hirano S., Kamei J. Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test. Neuropsychopharmacology 2004, 29:461-469.
46. Moghaddam H.K., Baluchnejadmojarad T., Roghani M., Goshadrou F., Ronaghi A. Berberine chloride improved synaptic plasticity in STZ induced diabetic rats. Metab. Brain Dis. 2013, 28:421-428.
47. Musen G. Cognition and brain imaging in type 1 diabetes, Curr. Diab. Rep 2008, 8:132-137.
48. Nacher J., Guirado R., Castillo-Gómez E. Structural plasticity of interneurons in the adult brain: Role of PSA-NCAM and implications for psychiatric disorders. Neurochem. Res. 2013, 38:1122-1133.
49. Nacher J., Pham K., Gil-Fernandez V., Mcewen B.S. Chronic restraint stress and chronic corticosterone treatment modulate differentially the expression of molecules related to structural plasticity in the adult rat piriform cortex. Neuroscience 2004, 126:503-509.
50. Nitta A., Murai R., Suzuki N., Ito H., Nomoto H., Katoh G., Furukawa Y., Furukawa S. Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol. Teratol. 2002, 24:695-701.
51. Oh D.H., Son H., Hwang S., Kim S.H. Neuropathological abnormalities of astrocytes, GABAergic neurons, and pyramidal neurons in the dorsolateral prefrontal cortices of patients with major depressive disorder. Eur. Neuropsychopharmacol. 2012, 22:330-338.
52. Pham K., Nacher J., Hof P.R., McEwen B.S. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur. J. Neurosci. 2003, 17:879-886.
53. Piroli G.G., Grillo C.A., Charron M.J., McEwen B.S., Reagan L.P. Biphasic effects of stress upon GLUT8 glucose transporter expression and trafficking in the diabetic rat hippocampus. Brain Res. 2004, 1006:28-35.
54. Pugh P.L., Ahmed S.F., Smith M.I., Upton N., Hunter A.J. A behavioural characterisation of the FVB/N mouse strain. Behav. Brain Res. 2004, 155:283-289.
55. Rajkowska G., O'Dwyer G., Teleki Z., Stockmeier C.A., Miguel-Hidalgo J.J. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 2007, 32:471-482.
56. Reagan L.P. Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications. Exp. Neurol. 2012, 233:68-78.
57. Reagan L.P., Magariños A.M., Yee D.K., Swzeda L.I., Van Bueren A., McCall A.L., McEwen B.S. Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Res. 2000, 862:292-300.
58. Reagan L.P., McEwen B.S. Diabetes, but not stress, reduces neuronal nitric oxide synthase expression in rat hippocampus: implications for hippocampal synaptic plasticity. Neuroreport 2002, 13:1801-1804.
59. Rees D.A., Alcolado J.C. Animal models of diabetes mellitus. Diabet. Med. 2005, 22:359-370.
60. Rowland N.E., Bellush L.L. Diabetes mellitus: stress, neurochemistry and behavior. Neurosci. Biobehav. Rev. 1989, 13:199-206.
61. Sairanen M., O'Leary O.F., Knuuttila J.E., Castrén E. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience 2007, 144:368-374.
62. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., Berman R.M., Charney D.S., Krystal J.H. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 1999, 56:1043-1047.
63. Sandi C. Stress, cognitive impairment and cell adhesion molecules. Nat. Rev. Neurosci. 2004, 5:917-930.
64. Sandi C., Merino J.J., Cordero M.I., Touyarot K., Venero C. Effects of chronic stress on contextual fear conditioning and the hippocampal expression of the neural cell adhesion molecule, its polysialylation, and L1. Neuroscience 2001, 102:329-339.
65. Sandrini M., Vitale G., Vergoni A., Ottani A., Bertolini A. Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain. Life Sci. 1997, 60:1393-1397.
66. Shalaby A., Kamal S. Effect of Escitalopram on GABA level and anti-oxidant markers in prefrontal cortex and nucleus accumbens of chronic mild stress-exposed albino rats. Int. J. Physiol. Pathophysiol. Pharmacol. 2009, 1:154-161.
67. Sharma V., Gilhotra R., Dhingra D., Gilhotra N. Possible underlying influence of p38MAPK and NF-κB in the diminished anti-anxiety effect of diazepam in stressed mice. J. Pharmacol. Sci. 2011, 116:257-263.
68. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl). 1985, 85:367-370.
69. Tay S.S., Wong W.C. Short- and long-term effects of streptozotocin-induced diabetes on the dorsal motor nucleus of the vagus nerve in the rat. Acta Anat. (Basel). 1994, 150:274-281.
70. Van Harten B., de Leeuw F.-E., Weinstein H.C., Scheltens P., Biessels G.J. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006, 29:2539-2548.
71. Varea E., Blasco-Ibáñez J.M., Gómez-Climent M.A., Castillo-Gómez E., Crespo C., Martínez-Guijarro F.J., Nácher J. Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex. Neuropsychopharmacology 2007, 32:803-812.
72. Varea E., Castillo-Gómez E., Gómez-Climent M.A., Blasco-Ibáñez J.M., Crespo C., Martínez-Guijarro F.J., Nàcher J. PSA-NCAM expression in the human prefrontal cortex. J. Chem. Neuroanat. 2007, 33:202-209.
73. Varea E., Nácher J., Blasco-Ibáñez J.M., Gómez-Climent M.A., Castillo-Gómez E., Crespo C., Martínez-Guijarro F.J. PSA-NCAM expression in the rat medial prefrontal cortex. Neuroscience 2005, 136:435-443.
74. Verrotti A., Scaparrotta A., Olivieri C., Chiarelli F. Seizures and type 1 diabetes mellitus: current state of knowledge. Eur. J. Endocrinol. 2012, 167:749-758.
75. Yun C., Xuefeng W. Association between seizures and diabetes mellitus: a comprehensive review of literature, Curr. Diabetes Rev. 2013, 9:350-354.